BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20428809)

  • 1. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1.
    Li R; Li G; Deng L; Liu Q; Dai J; Shen J; Zhang J
    Oncol Rep; 2010 Jun; 23(6):1553-9. PubMed ID: 20428809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines.
    Liu Q; Li G; Li R; Shen J; He Q; Deng L; Zhang C; Zhang J
    J Neurooncol; 2010 Nov; 100(2):165-76. PubMed ID: 20361349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
    Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
    J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.
    Senft C; Priester M; Polacin M; Schröder K; Seifert V; Kögel D; Weissenberger J
    J Neurooncol; 2011 Feb; 101(3):393-403. PubMed ID: 20589525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.
    Al-Alwan M; Olabi S; Ghebeh H; Barhoush E; Tulbah A; Al-Tweigeri T; Ajarim D; Adra C
    PLoS One; 2011; 6(11):e27339. PubMed ID: 22076152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
    Louca M; Zaravinos A; Stylianopoulos T; Gkretsi V
    Mol Cell Biochem; 2020 Aug; 471(1-2):143-153. PubMed ID: 32506247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin.
    Yang Y; Zhao Q; Cai Z; Cheng G; Chen M; Wang J; Zhong H
    PLoS One; 2015; 10(5):e0125132. PubMed ID: 25992623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.
    Wu J; Feng X; Zhang B; Li J; Xu X; Liu J; Wang X; Wang J; Tong X
    J Neurooncol; 2014 Oct; 120(1):33-41. PubMed ID: 25048528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of leucine aminopeptidase 3 suppresses invasion of ovarian cancer cells through down-regulation of fascin and MMP-2/9.
    Wang X; Shi L; Deng Y; Qu M; Mao S; Xu L; Xu W; Fang C
    Eur J Pharmacol; 2015 Dec; 768():116-22. PubMed ID: 26526349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma.
    Wang Q; Lu X; Wang J; Yang Z; Hoffman RM; Wu X
    Anticancer Res; 2018 Jun; 38(6):3267-3272. PubMed ID: 29848673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Girdin, an actin-binding protein, is critical for migration, adhesion, and invasion of human glioblastoma cells.
    Gu F; Wang L; He J; Liu X; Zhang H; Li W; Fu L; Ma Y
    J Neurochem; 2014 Nov; 131(4):457-69. PubMed ID: 25060559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A signal transducer and activator of transcription 3·Nuclear Factor κB (Stat3·NFκB) complex is necessary for the expression of fascin in metastatic breast cancer cells in response to interleukin (IL)-6 and tumor necrosis factor (TNF)-α.
    Snyder M; Huang J; Huang XY; Zhang JJ
    J Biol Chem; 2014 Oct; 289(43):30082-9. PubMed ID: 25213863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
    Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
    J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of STAT3 reduces astrocytoma cell invasion and constitutive activation of STAT3 predicts poor prognosis in human astrocytoma.
    Liang Q; Ma C; Zhao Y; Gao G; Ma J
    PLoS One; 2013; 8(12):e84723. PubMed ID: 24386409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.
    Jung TY; Jung S; Ryu HH; Jeong YI; Jin YH; Jin SG; Kim IY; Kang SS; Kim HS
    J Neurosurg; 2008 Aug; 109(2):273-84. PubMed ID: 18671640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.
    Pei J; Park IH; Ryu HH; Li SY; Li CH; Lim SH; Wen M; Jang WY; Jung S
    Radiat Oncol; 2015 Aug; 10():164. PubMed ID: 26245666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.